Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne F Jones

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2015
Molecular Pathways: Fatty Acid SynthaseSuzanne F Jones, Jeffrey R Infante
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 29, 2020
Molecular Profiling in Drug Development: Paving a Way ForwardSuzanne F Jones, Andrew J McKenzie
Expert Review of Molecular Diagnostics|January 9, 2019
Should next-generation sequencing tests be performed on all cancer patients?Andrew J McKenzie, Holli H Dilks, Suzanne F Jones, et al.
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
A phase I trial of vatalanib (PTK/ZK) in combination with bevacizumab in patients with refractory and/or advanced malignanciesSuzanne F Jones, David R Spigel, Denise A Yardley, et al.
The Oncologist|May 2, 2023
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic MalignanciesMelissa L Johnson, Manish R Patel, Raid Aljumaily, et al.
JCO Precision Oncology|January 7, 2022
Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint InhibitorsDaniel Schlauch, Xiaotong Fu, Suzanne F Jones, et al.
Journal of Clinical Pharmacology|June 9, 2015
Evaluation of CYP3A-mediated drug-drug interactions with romidepsin in patients with advanced cancerEric Laille, Manish Patel, Suzanne F Jones, et al.
Clinical Lung Cancer|November 6, 2003
Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patientsJohn D Hainsworth, Mark G Mainwaring, Melodie Thomas, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2012
A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumorsSuzanne F Jones, Jeffrey R Infante, Dana S Thompson, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2008
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapyAhmad Awada, Martine J Piccart, Suzanne F Jones, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2015
Molecular Pathways: Fatty Acid SynthaseSuzanne F Jones, Jeffrey R Infante
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 29, 2020
Molecular Profiling in Drug Development: Paving a Way ForwardSuzanne F Jones, Andrew J McKenzie
Expert Review of Molecular Diagnostics|January 9, 2019
Should next-generation sequencing tests be performed on all cancer patients?Andrew J McKenzie, Holli H Dilks, Suzanne F Jones, et al.
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
A phase I trial of vatalanib (PTK/ZK) in combination with bevacizumab in patients with refractory and/or advanced malignanciesSuzanne F Jones, David R Spigel, Denise A Yardley, et al.
The Oncologist|May 2, 2023
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic MalignanciesMelissa L Johnson, Manish R Patel, Raid Aljumaily, et al.
JCO Precision Oncology|January 7, 2022
Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint InhibitorsDaniel Schlauch, Xiaotong Fu, Suzanne F Jones, et al.
Journal of Clinical Pharmacology|June 9, 2015
Evaluation of CYP3A-mediated drug-drug interactions with romidepsin in patients with advanced cancerEric Laille, Manish Patel, Suzanne F Jones, et al.
Clinical Lung Cancer|November 6, 2003
Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patientsJohn D Hainsworth, Mark G Mainwaring, Melodie Thomas, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2012
A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumorsSuzanne F Jones, Jeffrey R Infante, Dana S Thompson, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2008
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapyAhmad Awada, Martine J Piccart, Suzanne F Jones, et al.
Pageof 7